Ginkgo
Unnamed: 1
Unnamed: 2
Ginkgo biloba L. (Ginkgoaceae)





Synonym(s) and related species


Fossil tree


Kew tree


Maidenhair tree


Salisburia adiantifolia Sm.


Salisuria biloba Hoffmanns





Monograph
Interpretation
Citation
Aminoglycosides
The interaction between ginkgo and amikacin is based on experimental evidence only.
Miman MC, Ozturan O, Iraz M, Erdem T, Olmez E, Amikacin ototoxicity enhanced by Ginkgo biloba extract (EGb 761). Hear Res (2002) 169, 121-9.
Antiepileptics
Case reports describe seizures in three patients taking valproate, or valproate and phenytoin, when ginkgo was also taken.
Kupiec T, Raj V. Fatal seizures due to potential herb-drug interactions with Ginkgo bilboa. J Anal Toxicol (2005) 29, 755-8.


Granger AS. Ginkgo biloba precipitating epileptic seizures. Age Ageing (2001) 30, 523-5.


Miwa H, Eijima M, Tanaka S, Mizuno Y. Generalised convulsions after a large amount of ginkgo nuts. Epilepsia (2001) 42, 280-281.
Antiplatelet drugs
Ginkgo biloba has been associated with platelet, bleeding, and clotting disorders, and there are isolated reports of serious adverse reactions after its concurrent use with antiplatelet drugs such as aspiring, clopidogrel, and triclopidine.
Aruna D, Naidu MUR, Pharmacodynamic interaction studies of Ginkgo biloba with zilostazol and clopidogrel in healthy human subjects. Br J Clin Pharmacol (2007) 63, 333-8.


Lu W-J, Huang J-d, Lai M-L. The effects of eroloid mesylates and Ginkgo biloba on the pharmacokinetics of ticlopidine. J Clin Pharmacol (2006) 46, 628-34.


Gardner CD, Zehnder JL, Ridby AJ, Nicholus JR, Farquhar JW. Effect of Ginkgo biloba (eGb 761) and aspirin on platelet aggregation and platelet function analysis amoung older adults at risk of cardiovascular disease: a randomized clinical trial. Blood Caogul Fibrinolysis (2007) 18, 787-93.


Wolf RHD. Does Ginkgo biloa special extract eGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicyclic acid 500 mg daily? Drugs R D (2006) 7, 163-72.


Ly J, Percy L, Dhanani S. Use of dietary supplements and their interactions with prescription drugs in the elderly. Am J Health-Syst Pharm (2002) 59, 1759-62.


Roscublatt M, Mindel J. Spontaneous hyphema associated with ingestion of Gingko biloba extract. N Engl J Med (1997) 336, 1108.


Griffiths J, Jordan S, Pilon S. Natural health products and adverse reactions. Can Adverse React News (2004) 14, 2-3.


Kim YS, Pyo Mk, Park KM, Park PH, Hahn BS, Wu SJ, Yun-Choi HS. Antiplatelet and antithromnotic effects of a combination of ticlopidine and Ginko bilboa ext (EGb 761). Thromb Res (1998) 91, 33-8.


Beckert BW, Comcanon MJ, Henry SL, Smith DS, Puckett CL. The effect of herbal medicines on platelet function: an in vivo experiment and review of the literature, Plast Reconstr Surg (2007) 120, 2044-50.


Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology (1996) 46, 1775-6.


Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba. Lancet (1998) 352, 36.


Bebbington A, Kulkarni R, Roberts P. Ginkgo biloba: persistent bleeding after total hip arthroplasty casued by herbal self-medication. J Anthorplasty (2005) 20, 125-6.


Gilbert GJ. Ginkgo biloba. Neurology (1997) 48, 1137.


Benjamin J, Muir T, Briggs K, Pentland B. A case of cerebral haemorrhage - can Ginkgo biloba be implicated? Postgrad Med J (2001) 77, 112-13.


Fong KCS, Kinnear PE. Retrobulbar haemorrhage associated with chronic Gingko [sic] biloba ingestion. Postgrade Med J (2003) 79, 531-2.


Fessenden JM, Wittenborn W, Clarke L. Gingko biloba: a case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy. Am Surg (2001) 67, 33-5.
Benzodiazepines
Ginkgo does not significantly affect the pharmacokinetics of alprazolam or diazepam.  Studies with midazolam suggest that ginkgo may increase, decrease, or have no effect on its metabolism.
Markowitz JS, Donovan JL, DeVane CL, Sipkes L, Chavin KD. Multiple-dose administration of Ginkgo bilboa did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers. J Clin Psychopharmacol (2003) 23, 576-81.


Zuo X-C, Zhang B-K, Jia S-J, Liu S-K, Zhou L-Y, Li J, Zhang J, Dai L-L, Chen B-M, Yang G-P, Yuan H. Effects of ginkgo biloba extracts on diazepam metabolism: a pharmacokinetic study in healthy Chinese male subjects Eur J Clin Pharmacol (2010) 66, 503-9.


Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CYW. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther (2002) 72, 276-87.


Zadoyan G, Rokitta D, Klement S, Dienel A, Hoerr R, Gramalle T, Fuhr U. Effect of Ginkgo bilboa special extract EFb 761 on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers. Eur J Clin Pharmacol (2012) 68, 553-60.


Robertson SM, Davey RT, Voell J, Formentini E, Alfaro RM, Penzak SR. Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects. Curr Med Res Opin (2008) 24, 591-9.


Uchida S, Yamada H, Li DX, Maruyama S, Ohmori Y, Oki T, Watanabe H, Umegaki K, Ohashi K, Yamada S. Effects of Ginkgo biloba extract on pharmacokinectics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers. J Clin Pharmacol (2006) 46, 1290-1298.


Chermat R, Brochet D, DeFeudis FV, Drien K. Interactions of Ginkgo biloba extract (EGb 761), diazepam and ethyl Î²-carboline-3-carboxylate on social behavior of the rat. Pharmacol Biochem Behav (1997) 56, 333-9.
Burpropion
Ginkgo does not appear to affect the pharmacokinetics of bupropion to a clinically relevant extent.
Lei H-P, Ji W, Lin J, Chen H, Tan Z-R, Hu D-L, Liu L-J, Zhou H-H. Effects of Ginkgo biloba extract on the pharmacokinetics of burpropion in healthy volunteers Br J Clin Pharmacol (2009) 68, 201-6.


Lau AJ, Chang TKH. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols. Drug Metab Dispos (2009) 37, 1931-7.
Buspirone
For a case of anxiety, with episodes of over-sleeping and memory deficits in a woman taking fluoxetine and busprione with st John's wort, ginkgo and melatonin, see St. John's wort + Buspirone, page 443.

Caffeine
Ginkgo does not appear to affect the pharmacokinetics of caffeine.
Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CYW. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther (2002) 72, 276-87.


Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CYW. Clinical assessment of botanical supplementation on cytochrome P450 phenotypes in the elderly: St. John's wort, garlic oil, Panax ginseng, and Ginkgo biloba. Drugs Aging (2005) 22, 525-39.


Zadoyan G, Rokitta D, Klement S, Dienel A, Hoerr R, Gramatte T, Fuhr U. Effect of Ginkgo biloba special extract EGb 761 on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers Eur J Clin Pharmacol (2012) 68, 553-60.
Calcium-channel blockers; Diltiazem
Ther interaction between ginkgo and diltiazem is based on experimental evidence only.
Ohnishi N, Kusuhara M, Yoshioka M, Kuroda K, Soga A, Nishikawa F, Koishi T, Nakagawa M, Hori S, Matsumoto T, Yamashita M, Ohta S, Takara K, Yokoyama T. Studies on interactions between functional foods or dietary supplements and medicines. I. Effects of Ginkgo biloba leaf extract on the pharmacokinetics of diltiazen in rats. Biol Pharm Bull (2003) 26, 1315-20.
Calcium-channel blockers; Nicardipine
The interaction between ginkgo and nicardipine is based on experimental evidence only.
Shinozuka K, Umegaki K, Kubota Y, Tanaka N, Mizuno H, Yamauchi J, Nakamura K, Kunitomo M. Feeding of Ginkgo biloba extract (GBE) enhances gene expression of hepatic cytochrome P-450 and attenuates the hypotensive effect of nicardipine in rats. Life Sci (2002) 70, 2783-92.


Kubota Y, Kobayashi K, Tanaka N, Nakamura K, Kunitomo M, Umegaki K, Shinozuka K.Interaction of Ginkgo biloba extract (GBE) with hypotensive agent, nicardipine, in rats. In Vivo (2003) 17, 409-12.
Calcium-channel blockers; Nifedipine
Ginkgo may increase the levels and some of the effects of nifedipine.
Smith M, Lin KM, Zheng YP. An open trial of nifedipine-herb interactions: nifedipine with St. John's wort, gingseng or Ginko [sic] biloba. Clin Pharmacol Ther (2002) 69, P86.


Yoshioka M, Ohnishi N, Koishi T, Obara Y, Nakagawa M, Matsumoto T, Tagagi K, Takara K, Ohkuni T, Yokoyama T, Kuroda K. Studies on interactions between functional food or dietary supplements and medicines. IV. Effects of Ginkgo biloba leaf extract on the pharmacokinetics and pharmacodynamics of nifedipine in healthy volunteers.Biol Pharm Bull (2004) 27, 2006-9.


Yoshioka M, Ohnishi N, Sone N, Egami S, Takara K, Yokoyama T, Kuroda K. Studies on interactions between functional foods or dietary supplements and medcines. III. Effects of Ginkgo biloba leaf extract on the pharmacokinetics of nifedipine in rats. Biol Pharm Bull (2004) 27, 2042-5.
Chlorzoxazone
Ginkgo does not appear to affect the pharmacokinetics of chlorzoxazone.
Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CYW. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther (2002) 72, 276-87.


Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CYW. Clinical assessment of botanical supplementation on cytochrome P450 phenotypes in the elderly: St. John's wort, garlic oil, Panax gingseng, and Ginkgo biloba. Drugs Aging (2005) 22, 525-39.
Ciclosporin
The interaction between ginkgo and ciclosporin is based on experimental evidence only.
Yang CY, Chao PDL, Hou YC, Tsai SY, Wen KC, Ksiu SL. Marked decreased of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats. Food Chem Toxicol (2006) 44, 1572-8.
Dextromethorphan
Ginkgo does not appear to affect the metabolism of dextromethorphan.
Markowitz JS, Donovan JL, DeVane CL, Sipkes L, Chavin KD. Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers. J Clin Psychopharmacol (2003) 23, 576-81.


Zadoyan G, Rokitta D, Klement S, Dienel A, Hoerr R, Gramatte T, Fuhr U. Effect of Ginkgo biloba special extract EGb 761 on human cytochrome P450 actvity a cocktail interaction study in healthy volunteers Eur J Clin Pharmacol (2012) 68, 553-60.


Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CYW. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans Clin Pharmacol Ther (2002) 72, 276-87.


urley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CYW. Clinical assessment of botanical supplementation on cytochrome P450 phenotypes in the elderly: St. John's wort, garlic oil, Panax gingseng and Ginko biloba. Drugs Aging (2005) 22, 525-39.


Hellum BH, Nilsen OG. The in vitro inhibitory potential of trade herbal products on human CYP2D6-mediated metabolism and the influence of ethanol. Basic Clin Pharmacol Toxicol (2007) 101, 250-358.


Hellum BH, Hu Z, Nilsen OG. The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes. Basic Clin Pharmacol Toxicol (2007) 100, 23-30.
Digoxin
Ginkgo does not appear to affect the pharmacokinetics of digoxin.
Mauro VF, Mauro LS, Kleshinski JF, Khuder SA, Wang Y, Erhardt PW. Impact of Ginkgo biloa on the pharmacokinetics of digoxin. Am J Ther (2003) 10, 247-51.


Hellum BH, Nilsen OG. In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products. Basic Clin Pharmacol Toxicol (2008) 102, 466-75.
Donepezil
Ginkgo does not appear to alter the pharmacokinetics or effect of donepezil.
Yasui-Furukori N, Furukori H, Kaneda A, Kaneko S, Tateishi T. The effects of Ginkgo biloba extract on the pharmacokietics and pharmacodynamics of donepezil. J Clin Pharmacol (2004) 44, 538-42.
Efavirenz
A case report suggests that ginkgo may reduce efavirenz levels.
Wiegman D-J, Brinkman K, Franssen EJF. Interaction of Ginkgo biloba with efavirenz. AIDS (2009) 23, 1184-5.
Fexofenadine
Ginkgo does not appear to affect the pharmacokinetics of fexofenadine.
Robertson SM, Davey RT, Voell J, Formentini E, Alfaro RM, Penzak SR. Effect of Ginkgo biloba extract of lopinavir, midazolam and fexofendaine pharmacokinetics in healthy subjects. Curr Med Res Opin (2008) 24, 591-9.
Food
No interactions found.

Haloperidol
Animal studies suggest that ginkgo may increase extrapyramidal effects in response to haloperidol,  but clinical studies do not appear to have reported this effect.
Zhang XY, Zhou DF, Su JM, Zhang PY. The effect of extract of Ginkgo bilboa added to haloperidol on superoxide dismutase in inpatients with chronic schizophrenia. J Clin Psychopharmacol (2001) 21, 85-8.


Fontant L, Souza AS, Del Bel EA, de Oliveira RMW. Ginkgo biloba leaf extract (EGb 761) enhance catalepsy induced by haloperidol and L-nitroarginine in mice. Braz J Med Biol Res (2005) 38, 1649-54.
Herbal medicines; Valerian
A case report describe psychotic symptoms in a woman who took ginkgo with valerian, but an interaction was not estalished as the cause.
Chen D, Klesmer J, Giovanniello A, Katz J. Mental status changes in an alcohol abuser taking valerian and Ginkgo biloba. Am J Addict (2002) 11, 75-7.
HIV-protease inhibitors
Ginkgo does not appear to affect the pharmacokinetics of lopinavir boosted with ritonavir.
Robertson SM, Davey RT, Voell J, Formentini E, Alfaro RM, Penzak SR. Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmazokinetics in healthy subjects. Curr Med Res Opin (2008) 24, 591-9.
Metformin
Ginkgo did not appear to alter the pharmacokinetics of metformin, and appeared to have a slight beneficial effect on glycaemic control.
Kudolo GB, Weng W, Javors M, Blodgett J. The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjects - a double blind placebo-controlled, crossover study Clin Nutr (2006) 25, 606-16.
NSAID
An isolated case describes fatal intracerebral bleeding in a patient taking ginkgo with ibuprofen, and another case describes prolonged bleeding and subdural haematomas in another patient taking gingko and rofecoxib. Studies with diclofenac and flurbiprofen showed that ginkgo had no effect on the pharmacokinetics of these drugs.
Meisel C, Johne A, Roots I. Fatal intracerebral mass bleeding associated with Ginkgo"
biloba and ibuprofen. Atherosclerosis (2003) 167, 367.


Hoffman T. Ginko, Vioxx and excessive bleeding â possible drug-herb interactions: case report. Hawaii Med J (2001) 60, 290.


Greenblatt DJ, von Moltke LL, Luo Y, Perloff ES, Horan KA, Bruce A, Reynolds RC, Harmatz JS, Avula B, Khan IA, Goldman P. Ginkgo biloba does not alter clearance of flurbiprofen, a cytochrome P450-2C9 substrate. J Clin Pharmacol (2006) 46, 214â21.


Mohutsky MA, Anderson GD, Miller JW, Elmer GW. Ginkgo biloba: evaluation of CYP2C9 drug interactions in vitro and in vivo. Am J Ther (2006) 13, 24â31.


Beckert BW, Concannon MJ, Henry SL, Smith DS, Puckett CL. The effect of herbal medicines on platelet function: an in vivo experiment and review of the literature. Plast Reconstr Surg (2007) 120, 2044â50.


Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology (1996) 46, 1775â6.


Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba. Lancet (1998) 352, 36.


Gilbert GJ. Ginkgo biloba. Neurology (1997) 48, 1137.


Benjamin J, Muir T, Briggs K, Pentland B. A case of cerebral haemorrhage â can Ginkgo biloba be implicated? Postgrad Med J (2001) 77, 112â13.


Fong KCS, Kinnear PE. Retrobulbar haemorrhage associated with chronic Gingko biloba ingestion. Postgrad Med J (2003) 79, 531â2.


Fessenden JM, Wittenborn W, Clarke L. Gingko biloba: a case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy. Am Surg (2001) 67, 33â5.


Griffiths J, Jordan S, Pilon S. Natural health products and adverse reactions. Can Adverse React News (2004) 14, 2â3.
Phenobarbital
The interaction between ginkgo and phenobarbital is based on experimental evidence only
Kubota Y, Kobayashi K, Tanaka N, Nakamura K, Kunitomo M, Umegaki K, Shinozuka K. Pretreatment with Ginkgo biloba extract weakens the hypnosis action of phenobarbital and its plasma concentration in rats. J Pharm Pharmacol (2004) 56, 401â5.
Propranolol
The interaction between ginkgo and propranolol is based on experimental evidence only.
Zhao L-Z, Huang M, Chen J, Ee PLR, Chan E, Duan W, Guan Y-Y, Hong Y-H, Chen X, Zhou S. Induction of propranolol metabolism by Ginkgo biloba extract EGb 761 in rats. Curr Drug Metab (2006) 7, 577â87.
Proton pump inhibitors
Ginkgo induces the metabolism of omeprazole. Most other proton pump inhibitors are likely to be similarly affected.
Yin OQP, Tomlinson B, Waye MMY, Chow AHL, Chow MSS. Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole. Pharmacogenetics (2004) 14, 841â50.


Zadoyan G, Rokitta D, Glement S, Dienel A, Hoerr R, Gramatte T, Fuhr U. Effect of Ginko biloba special extract EGv 761 on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers Eur J Clin Pharmacol (2012) 68, 553-60.
Risperidone
An isolated case describes priapism in a patient taking risperidone and ginkgo.
Lin Y-Y, Chu S-J, Tsai S-H. Association between priapism and concurrent use of risperidone and Ginkgo biloba. Mayo Clin Proc (2007) 82, 1288â91.
Talinolol
Ginkgo slightly increases the exposure to talinolol.
Fan L, Tao G-Y, Chen Y, He Y-J, Li Q, Lei H-P, Jiang F, Hu D-L, Huang Y-F, Zhou H-H. Effects of ginkgo biloba extract ingestion on the pharmacokinetics of talinolol in healthy Chinese volunteers Ann Pharmacother (2009) 43, 944-9.


Fan L, Mao X-Q, Tao G-Y, Wang G, Jiang F, Chen Y, Li Q, Zhang W, Lei H-P, Hu D-L, Huang Y-F, Wang D, Zhou H-H. Effect of Schisandra chinensis extract and Ginkgo biloba extract on the pharmacokinetics of talinolol in healthy volunteers. Xenobiotica (2009) 39 249-54.


Hellum BH, Nilsen OG. In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products. Basic Clin Pharmacol Toxicol (2008) 102, 466-75.
Theophylline
The interaction between ginkgo and theophylline is based on experimental evidence only.
Tang J, Sun J, Zhang Y, Li L, Cui F, He Z. Herb-drug interactions: Effect of Ginkgo biloba extract on the pharmacokinetics of theophylline in rats. Food Chem Toxicol (2007) 45, 2441â5.
Tolbutamide
Gingko does not appear to have a clinically relevant effect on the metabolism or blood-glucose-lowering effects of tolbutamide.
Mohutsky MA, Anderson GA, Miller JW, Elmer GW. Ginkgo biloba: evaluation of CYP2C9 drug interactions in vitro and in vivo. Am J Ther (2006) 13, 24â31.


Uchida S, Yamada H, Li DX, Maruyama S, Ohmori Y, Oki T, Watanabe H, Umegaki K, Ohashi K, Yamada S. Effects of Ginkgo biloba extract on pharmacokinetics and


pharmacodynamics of tolbutamide and midazolam in healthy volunteers. J Clin Pharmacol (2006) 46, 1290â8.


Sugiyama T, Kubota Y, Shinozuka K, Yamada S, Wu J, Umegaki K. Ginkgo biloba extract modifies hypoglycemic action of tolbutamide via hepatic cytochrome P450 mediated mechanism in aged rats. Life Sci (2004) 75, 1113â22.
Trazodone
Coma developed in an elderly patient with Alzheimerâs disease after she took trazodone and ginkgo.
Galluzzi S, Zanetti O, Binetti G, Trabucchi M, Frisoni GB. Coma in a patient with Alzheimerâs disease taking low dose trazodone and ginkgo biloba. J Neurol Neurosurg Psychiatry (2000) 68, 679â80.
Warfarin and related drugs
Evidence from pharmacological studies in patients and healthy subjects suggests that ginkgo does not usually interact with warfarin. However, an isolated report describes intracerebral haemorrhage associated with the use of ginkgo and warfarin, and there are a few reports of bleeding associated with the use of ginkgo alone.
Engelsen J, Nielsen JD, Winther K. Effect of coenzyme Q10 and ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients. A randomised, double blind, placebo-crossover trial. Thromb Haemost (2002) 87, 1075â6.


Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, Day RO, McLachlan AJ. Effect of ginkgo and ginger on the pharmacokinetics and


pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol (2005) 59, 425â32.


Lai C-F, Chang C-C, Fu C-H, Chen C-M. Evaluation of the interaction between warfarin and ginkgo biloba extract. Pharmacotherapy (2002) 22, 1326.


Matthews MK. Association of Ginkgo biloba with intracerebral hemorrhage. Neurology (1998) 50, 1933.


Vaes LPJ, Chyka PA. Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence. Ann Pharmacother (2000) 34, 1478â82.
